News

Almac has implemented biocatalytic technology for metabolite synthesis, isolation and structural identification. Metabolite synthesis is another tool within selectAZyme’s service providing access to both oxidative and glycosylated products.

Paclical is indicated for ovarian cancer and lung cancer. Oasmia has developed a water soluble formulation of Paclitaxel with the retinoid based platform XR-17. Oasmia claims Paclitaxel does

The PBS 3 bioreactor with patented Air-Wheel system employs a low shear, pneumatic mixing mechanism, and has a 3-liter maximum working volume capacity. The feature of fast mixing

The company has reported a net income of $5.1m, or $0.12 per diluted share, against net income of $4.85m or $0.11 per diluted share, for the same period

The new manufacturing site is a part of an expansion project within Biovest’s 35,000sqft cell culture center in Coon Rapids. The new expanded facility will manufacture Biovest’s late-stage,

The company has posted a net loss of $357,802 for the third quarter 2011, or $0.01 loss per diluted share, compared to net income of $2.1m, or $0.08

Insys uses proprietary technologies for the development of product candidates that address the clinical shortcomings of existing commercial products. Insys CEO Michael Babich said they are excited to

EX101 is a proprietary buffered effervescent dosage form of alendronate sodium administered once weekly. It is indicated to treat osteoporosis in postmenopausal women and increase bone mass in

SynCo Bio Partners is a biopharmaceutical GMP Contract Manufacturing Organization licensed for clinical and commercial GMP manufacturing of Bulk Drug Substances and Drug Products. As per the agreement,